Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Nuclear Medicine: Page 279
NRG starts process for new reactor
By
AuntMinnie.com staff writers
Dutch radiopharmaceutical producer Nuclear Research and Consultancy Group (NRG) has begun the regulatory approval process to build a nuclear reactor to replace its High Flux Reactor.
November 19, 2009
VisEn debuts new molecular imaging agents
By
AuntMinnie.com staff writers
Optical imaging developer VisEn Medical has launched two new molecular imaging agents.
November 19, 2009
Covidien shows mixed results in Q4, fiscal 2009
By
AuntMinnie.com staff writers
Healthcare technology firm Covidien has reported mixed results for its fourth quarter and fiscal 2009.
November 19, 2009
Early FDG-PET/CT may help head and neck cancer therapy
By
Wayne Forrest
Changes in standardized uptake values on FDG-PET/CT scans may be "significantly predictive of tumor recurrence" in patients with squamous cell cancer of the neck and head, according to a new study from Wake Forest University School of Medicine in Winston-Salem, NC.
November 19, 2009
Positron wins New York PET contract
By
AuntMinnie.com staff writers
Molecular imaging vendor Positron has inked a contract for its dedicated cardiac PET scanner with a New York imaging center.
November 18, 2009
GE touts ADMIRE-HF clinical results
By
AuntMinnie.com staff writers
GE Healthcare is touting two new clinical studies that offer encouraging results for its AdreView radiopharmaceutical in heart failure patients at risk for cardiac death, disease progression, or cardiac arrhythmias.
November 16, 2009
eRad closes on Illinois install
By
AuntMinnie.com staff writers
PACS firm eRad has installed its eRad PACS with PET/CT Fusion diagnostic tools at Molecular Imaging in Hinsdale, IL.
November 16, 2009
PET/CT directs head and neck cancer treatment
By
AuntMinnie.com staff writers
PET/CT conducted six to eight weeks after patients complete chemoradiotherapy for head and neck cancer may help identify those who will respond to treatment and those who will require surgical follow-up, according to a report in the November issue of the
Archives of Otolaryngology -- Head & Neck Surgery
.
November 16, 2009
FDG-PET/CT helps manage treatment for Crohn's disease
By
Wayne Forrest
A new study has found that FDG-PET/CT can provide important information on patients with Crohn's disease that can help determine whether medical therapy or surgery is the correct course of action.
November 15, 2009
Radiotherapy exploits advances in diagnostic imaging
By
Tami Freeman
Imaging plays a major role throughout the entire cancer management process -- from diagnosis and staging, to therapy planning and delivery, to response monitoring and surveillance, according to a presentation at the recent American Society for Radiation Oncology meeting in Chicago.
November 12, 2009
Positron touts new Medicare PET rates
By
AuntMinnie.com staff writers
Molecular imaging vendor Positron expects the shift from cardiac SPECT to cardiac PET imaging will accelerate now that the U.S. Centers for Medicare and Medicaid Services (CMS) has released its 2010 Medicare Physician Fee Schedule.
November 11, 2009
Mirada lands Louisiana installs
By
AuntMinnie.com staff writers
Medical imaging software developer Mirada Medical of Oxford, U.K., has installed its software at a Louisiana health system.
November 11, 2009
Previous Page
Page 279 of 440
Next Page